Arbeitspapier
mRNA vaccines: A lucky shot?
MRNA technology has proved in the context of the COVID-19 pandemic its breakthrough value as a basis for vaccines. There has been rapid development of highly safe, effective and robust mRNA vaccines, and these can be delivered at large scale. Yet the technology is the result of a long process of accumulation of innovation and capacity. It was a bumpy process that could easily have turned out differently. The mRNA vaccines story suggests that a vibrant vaccine ecosystem cannot be taken for granted in terms of delivering the breakthroughs needed for global pandemic preparedness and response. This paper examines the background of mRNA technology development to understand better how public vaccine research and development policy can be improved to generate the full global social benefits from breakthrough novel vaccine technologies, like mRNA.
- Sprache
-
Englisch
- Erschienen in
-
Series: Bruegel Working Paper ; No. 13/2021
health economics and policy
technology
vaccines
- Handle
- Letzte Aktualisierung
-
20.09.2024, 08:22 MESZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Veugelers, Reinhilde
- Bruegel
Entstanden
- 2021
Ähnliche Objekte (12)
The challenge of China’s rise as a science and technology powerhouse
Assessing the potential for knowledge-based development in the transition countries of Central and Eastern Europe, the Caucasus and Central Asia
Research and innovation policies and productivity growth
Are European firms falling behind in the global corporate research race?
Undercutting the future? European research spending in times of fiscal consolidation
New ICT sectors: Platforms for European growth?
The European Union's growing innovation divide
Innovation in EU merger control: Walking the talk
Mixing and matching research and innovation policies in EU countries
Mind Europe's early-stage equity gap
The world innovation landscape: Asia rising?
Europe's clean technology investment challenge
The challenge of China’s rise as a science and technology powerhouse
Assessing the potential for knowledge-based development in the transition countries of Central and Eastern Europe, the Caucasus and Central Asia
Research and innovation policies and productivity growth
Are European firms falling behind in the global corporate research race?
Undercutting the future? European research spending in times of fiscal consolidation
New ICT sectors: Platforms for European growth?
The European Union's growing innovation divide
Innovation in EU merger control: Walking the talk
Mixing and matching research and innovation policies in EU countries
Mind Europe's early-stage equity gap
The world innovation landscape: Asia rising?
Europe's clean technology investment challenge
The challenge of China’s rise as a science and technology powerhouse
Assessing the potential for knowledge-based development in the transition countries of Central and Eastern Europe, the Caucasus and Central Asia
Research and innovation policies and productivity growth
Are European firms falling behind in the global corporate research race?
Undercutting the future? European research spending in times of fiscal consolidation
New ICT sectors: Platforms for European growth?
The European Union's growing innovation divide
Innovation in EU merger control: Walking the talk
Mixing and matching research and innovation policies in EU countries
Mind Europe's early-stage equity gap
The world innovation landscape: Asia rising?